LON:EKF EKF Diagnostics (EKF) Share Price, News & Analysis GBX 31.04 +0.84 (+2.78%) As of 07:18 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About EKF Diagnostics Stock (LON:EKF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EKF Diagnostics alerts:Sign Up Key Stats Today's Range 30.20▼ 31.7050-Day Range 25.90▼ 31.9052-Week Range 18.40▼ 32Volume815,227 shsAverage Volume421,617 shsMarket Capitalization£139.40 millionP/E Ratio2,299.26Dividend Yield4.65%Price TargetN/AConsensus RatingN/A Company Overview EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide. Read More Receive EKF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EKF Stock News HeadlinesEKF Diagnostics Holdings (LON:EKF) shareholders have endured a 44% loss from investing in the stock five years agoOctober 6 at 4:48 AM | finance.yahoo.comEKF Diagnostics Implements Long Term Incentive Plan for ExecutivesSeptember 16, 2025 | tipranks.comTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.October 6 at 2:00 AM | Porter & Company (Ad)Major contract wins for diagnostics firm EKF in Africa and Latin AmericaAugust 26, 2025 | msn.comEKF Diagnostics Secures €4.65m Hematology Contracts, Expands Production CapacityAugust 26, 2025 | msn.comMajor contracts wins for diagnostics firm EKF in Africa and Latin AmericaAugust 26, 2025 | msn.comEkf Diagnostics Share Chat. Chat About EKF Shares. Join in the Conversation with Ekf Diagnostics Share Discussion. - London South EastJune 26, 2025 | lse.co.ukEKF Diagnostics cancels 5.8 million treasury sharesJune 26, 2025 | investing.comSee More Headlines EKF Stock Analysis - Frequently Asked Questions How have EKF shares performed this year? EKF Diagnostics' stock was trading at GBX 27 on January 1st, 2025. Since then, EKF shares have increased by 15.0% and is now trading at GBX 31.04. How were EKF Diagnostics' earnings last quarter? EKF Diagnostics Holdings plc (LON:EKF) announced its quarterly earnings data on Tuesday, September, 16th. The company reported $0.43 earnings per share for the quarter. EKF Diagnostics had a trailing twelve-month return on equity of 7.03% and a net margin of 9.37%. How do I buy shares of EKF Diagnostics? Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of EKF Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that EKF Diagnostics investors own include ERBA Diagnostics (ERBA), boohoo group (BOO), Lloyds Banking Group (LLOY), 888 (888), Abcam (ABC), ASOS (ASC) and Babcock International Group (BAB). Company Calendar Last Earnings9/16/2025Today10/06/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:EKF CIKN/A Webwww.ekfdiagnostics.com Phone+44-29-20710570FaxN/AEmployees356Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.01 Trailing P/E Ratio2,299.26 Forward P/E Ratio13.50 P/E GrowthN/ANet Income£4.68 million Net Margins9.37% Pretax MarginN/A Return on Equity7.03% Return on Assets5.27% Debt Debt-to-Equity Ratio0.34 Current Ratio4.60 Quick Ratio1.77 Sales & Book Value Annual Sales£50.22 million Price / Sales2.78 Cash FlowGBX 2.92 per share Price / Cash Flow10.64 Book ValueGBX 15.41 per share Price / Book2.01Miscellaneous Outstanding Shares449,094,000Free FloatN/AMarket Cap£139.40 million OptionableNot Optionable Beta0.57 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (LON:EKF) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthGovernment Gridlock – The Final Act in a Collapse Trump's extension of this wealth saving loophole may be y...American Hartford Gold | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | SponsoredWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EKF Diagnostics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share EKF Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
